Teleflex Incorporated (TFX)
| Market Cap | 13.43B |
| Revenue (ttm) | 2.82B |
| Net Income (ttm) | 487.65M |
| Shares Out | 46.90M |
| EPS (ttm) | 10.28 |
| PE Ratio | 27.85 |
| Forward PE | 20.12 |
| Dividend | $1.36 (0.47%) |
| Ex-Dividend Date | May 13, 2022 |
| Volume | 605,988 |
| Open | 290.19 |
| Previous Close | 292.76 |
| Day's Range | 285.52 - 291.47 |
| 52-Week Range | 256.77 - 428.36 |
| Beta | 1.05 |
| Analysts | Buy |
| Price Target | 366.28 (+27.9%) |
| Earnings Date | Apr 28, 2022 |
About TFX
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional prod...
Financial Performance
In 2021, Teleflex's revenue was $2.81 billion, an increase of 10.74% compared to the previous year's $2.54 billion. Earnings were $485.37 million, an increase of 44.75%.
Financial StatementsAnalyst Forecast
According to 15 analysts, the average rating for TFX stock is "Buy." The 12-month stock price forecast is 366.28, which is an increase of 27.92% from the latest price.
News
Teleflex Announces Regulatory Clearance for its UroLift® System in China for the Treatment of Benign Prostatic Hyperp...
Will expand patient access to BPH treatment Will expand patient access to BPH treatment
Teleflex Announces Health Canada Approval of MANTA® Vascular Closure Device
WAYNE, Pa., May 18, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today has announced that it received Health Canada approval for the MAN...
Teleflex Announces Full U.S. Commercial Launch of the UroLift® 2 System and UroLift ATC ® Advanced Tissue Control System
Product demonstrations and educational presentations underscore the company's leadership in advancing care for patients with benign prostatic hyperplasia (BPH) Product demonstrations and educational pre...
Teleflex to Host Analyst & Investor Day on May 20, 2022
WAYNE, Pa., May 02, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced that the Company will host an Analyst & Investor Day on Friday, May 20, 2022 in New York Ci...
Teleflex Announces Quarterly Dividend
WAYNE, Pa., May 02, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of co...
Teleflex's (TFX) Q1 Earnings Top Estimates, Margins Down
Teleflex (TFX) exhibits year-over-year growth across the Americas, EMEA and Asia regions at CER in the first quarter.
Teleflex (TFX) Tops Q1 Earnings and Revenue Estimates
Teleflex (TFX) delivered earnings and revenue surprises of 5.49% and 1.58%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Teleflex Reports First Quarter Financial Results And Full Year Outlook
WAYNE, Pa., April 28, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the first quarter ended March 27, 2022.
Teleflex Named to Forbes Best Employers for Diversity 2022 List
WAYNE, Pa., April 26, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it has been named to the Forbes Best Employers for Di...
Teleflex to Present at the Bank of America Securities 2022 Healthcare Conference
WAYNE, Pa., April 26, 2022 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Bank of America Securities 2022 Healthcare Confere...
Teleflex (TFX) Expected to Beat Earnings Estimates: Should You Buy?
Teleflex (TFX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Teleflex Announces First Quarter 2022 Earnings Conference Call Information
WAYNE, Pa., April 14, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its first quarter 2022 results, and provide an operational update at 8:00 a.m. East...
Teleflex Announces the Launch of the UroLift® System in Japan for the Treatment of Benign Prostatic Hyperplasia (BPH)
Initial Cases Have Now Been Performed in Japan Initial Cases Have Now Been Performed in Japan
Here's Why You Should Retain Teleflex (TFX) Stock for Now
Investors are optimistic about Teleflex (TFX) on increased UroLift demand and strong vascular business.
Teleflex (TFX) Hurt by Urolift Cancellations, Cost Woes
Teleflex (TFX) continues to face supply-chain challenges and freight logistic delays.
Teleflex to Present at the KeyBanc Life Sciences & MedTech Investor Forum
WAYNE, Pa., March 09, 2022 (GLOBE NEWSWIRE) -- Thomas Powell, Executive Vice President and Chief Financial Officer, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the KeyBanc Life Sciences ...
Teleflex to Present at the 43rd Annual Raymond James Institutional Investors Conference
WAYNE, Pa., March 02, 2022 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 43rd Annual Raymond James Institutional Investors ...
Teleflex (TFX) Q4 Earnings & Revenues Top Estimates, Margins Up
Strong segmental performance in the domestic and international markets is driving Teleflex's (TFX) fourth-quarter top line.
Teleflex (TFX) Q4 Earnings and Revenues Surpass Estimates
Teleflex (TFX) delivered earnings and revenue surprises of 1.98% and 1.87%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Teleflex Announces Fourth Quarter and Full-Year 2021 Financial Results
WAYNE, Pa., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the fourth quarter ended December 31, 2021.
Teleflex Receives FDA Clearance for Expanded Indication for Specialty Catheter and Coronary Guidewire Use in CTO PCI ...
Results of CTO-PCI IDE Study Demonstrate Procedural Success with Teleflex Specialty Catheters and Coronary Guidewires in Patients Undergoing Chronic Total Occlusion Percutaneous Coronary Interventions R...
Teleflex (TFX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Teleflex (TFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Teleflex Announces Fourth Quarter and Full Year 2021 Earnings Conference Call Information
WAYNE, Pa., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its fourth quarter and full year 2021 financial results and provide an operational u...
Teleflex to Present at the 40th Annual J.P. Morgan Healthcare Conference
WAYNE, Pa., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 40th Annual J.P. Morgan Healthcare Conference on Tu...
Teleflex (TFX) Banks on Urolift Growth Amid Rising Expenses
Despite reporting softer-than-expected revenues for the third quarter, Teleflex (TFX) notes that customer preference for UroLift continues to be driven by strong clinical results.